Overuse of medication as risk factor of chronic headache

被引:0
|
作者
Katsarava, Z. [1 ]
Zwarg, T. [1 ]
Wallasch, T. -M. [2 ]
机构
[1] Univ Klinikum Essen, Neurol Klin, D-45122 Essen, Germany
[2] Lehrkrankenhaus Charite, Sankt Gertrauden Krankenhaus Berlin, Klin Interdisziplinare Schmerztherapie, Kopf Schmerzzentrum, Berlin, Germany
关键词
Medication overuse; chronic headache; migraine; tension-type headache; SEROTONIN SYNTHESIS; WITHDRAWAL; SUMATRIPTAN; CAFFEINE; FEATURES; THERAPY; ABUSE; ZOLMITRIPTAN; ANALGESICS; PREDICTORS;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The international headache society defines headache as chronic if it occurs on more than 15 days per month. The vast majority of patients suffering from chronic headache have medication overuse headache, chronic migraine or chronic tension-type headache. Frequent intake (overuse) of acute headache drugs is probably the most important risk factor leading do the development of medication overuse headache (MOH). The prevalence of MOH reaches approximately 1% of the world's population and shows an increasing trend. Many important studies on medication overuse headache have been published. Some of them investigated the pathophysiology of headache chronification others focused on the evaluation of risk factors. The IHS revised its classification criteria on MOH. Several large population based longitudinal studies clearly demonstrated that overuse of any kind of acute headache medication is the main risk factor leading to the development of chronic headache. Management of MOH remains difficult. The only effective treatment concept remains consequent withdrawal therapy.
引用
收藏
页码:373 / 377
页数:5
相关论文
共 50 条
  • [31] Medication overuse headache
    Williams, David
    AUSTRALIAN PRESCRIBER, 2005, 28 (06) : 143 - 145
  • [32] Chronic migraine and headache by medication overuse. Evolution and revision of classification
    Goebel, H.
    Heinze, A.
    SCHMERZ, 2011, 25 (05): : 493 - +
  • [33] Medication Overuse Headache in Patients with Primary Headache DisordersEpidemiology, Management and Pathogenesis
    Andrew J. Dowson
    David W. Dodick
    Volker Limmroth
    CNS Drugs, 2005, 19 : 483 - 497
  • [34] European Academy of Neurology guideline on the management of medication-overuse headache
    Diener, H. C.
    Antonaci, F.
    Braschinsky, M.
    Evers, S.
    Jensen, R.
    Lainez, M.
    Kristoffersen, E. S.
    Tassorelli, C.
    Ryliskiene, K.
    Petersen, J. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (07) : 1102 - 1116
  • [35] Monitoring chronic headache and medication-overuse headache prevalence in Denmark
    Westergaard, Maria Lurenda
    Lau, Cathrine Juel
    Allesoe, Karen
    Gjendal, Signe Thorup
    Jensen, Rigmor Hojland
    CEPHALALGIA, 2020, 40 (01) : 6 - 18
  • [36] Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial
    Schwedt, Todd J.
    Hentz, Joseph G.
    Sahai-Srivastava, Soma
    Spare, Nicole M.
    Martin, Vincent T.
    Treppendahl, Christina
    Digre, Kathleen
    Bennett, Nathan L.
    Birlea, Marius
    Watson, David
    Murinova, Natalia
    Robert, Teri
    Dodick, David W.
    HEADACHE, 2021, 61 (02): : 351 - 362
  • [37] Medication-overuse headache: a review
    Kristoffersen, Espen Saxhaug
    Lundqvist, Christofer
    JOURNAL OF PAIN RESEARCH, 2014, 7 : 367 - 378
  • [38] Dependent Behavior in Patients with Medication-Overuse Headache
    Fuh, Jong-Ling
    Wang, Shuu-Jiun
    CURRENT PAIN AND HEADACHE REPORTS, 2012, 16 (01) : 73 - 79
  • [39] Medication-overuse headache: epidemiology, diagnosis and treatment
    Kristoffersen, Espen Saxhaug
    Lundqvist, Christofer
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2014, 5 (02) : 87 - 99
  • [40] Prevalence of medication overuse headache in an interdisciplinary pain clinic
    Schmid, Corinne Wanner
    Maurer, Konrad
    Schmid, Daniel M.
    Alon, Eli
    Spahn, Donat R.
    Gantenbein, Andreas R.
    Sandor, Peter S.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14